Prakt. lékáren. 2013; 9(4-5): 192-195

New medicinal substances in extemporaneous prescription - miconazole and miconazole nitrate

Jan Hašek
Lékárna U Matky Boží, Doksy

Miconazole is the second azole antifungal drug and the third specific antifungal agent in succession among the newly available pharmaceutical

substances that are currently available for extemporaneous preparation in pharmacies. It has a fungistatic to fungicidal activity,

acting even on gram-positive bacteria. The article deals with the pharmacotherapeutic and galenic properties of this substance.

Attention is paid to formulas for the treatment of oropharyngeal candidiases – hydrophilic gel with miconazole, and the treatment of

dermatomycoses – hydrophilic creams, ointment. Technologically, miconazole and miconazole nitrate are relatively stable pharmaceutical

substances; they are stable not only at higher temperatures, but also, in contrast to clotrimazole, in a wider range of pH.

Keywords: miconazole, azole antifungals, oral candidiasis, diaper dermatitis, extemporaneous preparation

Published: October 15, 2013  Show citation

ACS AIP APA ASA Harvard Chicago Chicago Notes IEEE ISO690 MLA NLM Turabian Vancouver
Hašek J. New medicinal substances in extemporaneous prescription - miconazole and miconazole nitrate. Praktické lékárenství. 2013;9(4-5):192-195.
Download citation

References

  1. Piérard GE, Hermanns-L? T, Delvenne P, Piérard-Franchimont C. Miconazole, a pharmacological barrier to skin fungal infections. Expert Opin Pharmacother 2012; 13(8): 1187-1194. Go to original source... Go to PubMed...
  2. Ellepola AN, Samaranayake LP. Oral candidal infections and antimycotics. Crit Rev Oral Biol Med. 2000; 11(2): 172-198. Go to original source... Go to PubMed...
  3. Krausová L, Grim J, Pávek P. Azolová antimykotika: mechanizmy lékových interakcí. Klin Farmakol Farm 2009; 23(2): 86-89.
  4. Musaji N. Antifungal drug resistance: not all azoles are equal. Expert Rev Anti Infect Ther 2010; 8(5): 515-516. Go to original source... Go to PubMed...
  5. Barasch A, Griffin AV. Miconazole revisited: new evidence of antifungal efficacy from laboratory and clinical trials. Future Microbiol 2008; 3(3): 265-269. Go to original source... Go to PubMed...
  6. Rezepturhinweise: Miconazol, Neues Rezeptur-Formularium, Pharmazeutische Zeitung, Govi-Verlag und Stuttgart: Deutscher Apotheker-Verlag, 2009.
  7. Quatresooz P, Vroome V, Borgers M, Cauwenbergh G, Piérard GE. Novelties in the multifaceted miconazole effects on skin disorders. Expert Opin Pharmacother 2008; 9(11): 1927-1934. Go to original source... Go to PubMed...
  8. Heeres J, Meerpoel L, Lewi P. Conazoles. Molecules 2010; 15(6): 4129-4188. Go to original source... Go to PubMed...
  9. Hoppe JE, Hahn H. Randomized comparison of two nystatin oral gels with miconazole oral gel for treatment of oral thrush in infants. Antimycotics Study Group. Infection 1996; 24(2): 136-139. Go to original source... Go to PubMed...
  10. Hoppe JE. Treatment of oropharyngeal candidiasis in immunocompetent infants: a randomized multicenter study of miconazole gel vs. nystatin suspension. The Antifungals Study Group. Pediatr Infect Dis J 1997; 16(3): 288-293. Go to original source... Go to PubMed...
  11. Blanco D, van Rossem K. A Prospective Two-Year Assessment of Miconazole Resistance in Candida Spp. with Repeated Treatment with 0.25% Miconazole Nitrate Ointment in Neonates and Infants with Moderate to Severe Diaper Dermatitis Complicated by Cutaneous Candidiasis. Pediatr Dermatol 2013 (v tisku, bude doplněno). Go to original source... Go to PubMed...
  12. Bukvić Mokos Z, Kralj M, Basta-Juzbašić A, Lakoš Jukić I. Seborrheic dermatitis: an update. Acta Dermatovenerol Croat 2012; 20(2): 98-104. Go to PubMed...
  13. Al-Badr AA. Miconazole nitrate: comprehensive profile. Profiles Drug Subst Excip Relat Methodol 2005; 32: 3-65. Go to original source... Go to PubMed...
  14. Dokumentace účinných látek: Mikonazol-nitrát. GD Gesellschaft für Dermopharmazie, Köln. 2009. Dostupné na webových stránkách http://www.gd-online.de/german/veranstalt/Wirkstoffdossiers_1 9.11.200 9.htm Datum náhledu 8. 6. 2013.
  15. Deutscher Arzneimittel-Codex (DAC) 2007/Neues Rezeptur-Formularium (NRF). Band I-III. Pharmazeutischen Laboratorium des NRF. Eschborn: Govi-Verlag und Stuttgart: Deutscher Apotheker-Verlag, 2006.
  16. Kinget R. Galenisch formularium Met inleiding op het medisch voorschrift. 2. revid. vyd. Leuven/Apeldoorn: Garant 2000: 235.
  17. Niazi S. Handbook of pharmaceutical manufacturing formulations - Část 4. Semisolid products. Boca Raton: CRC Press 2004: 263. Go to original source...
  18. Therapeutisch Magistraal Formularium. Medisch farmaceutische kwaliteitszorg. Vydání 2010. Dostupné na webu http://www.mfk-qmp.be/Datum náhledu 9. 6. 2013.
  19. SPC přípravku Loramyc 50 mg, dostupné na www.sukl.cz Datum náhledu 4. 9. 2013.
  20. Pharmindex Compendium. Medimedia Information, Praha 2001: 1802.




Pharmacy for Practice

Madam, Sir,
please be aware that the website on which you intend to enter, not the general public because it contains technical information about medicines, including advertisements relating to medicinal products. This information and communication professionals are solely under §2 of the Act n.40/1995 Coll. Is active persons authorized to prescribe or supply (hereinafter expert).
Take note that if you are not an expert, you run the risk of danger to their health or the health of other persons, if you the obtained information improperly understood or interpreted, and especially advertising which may be part of this site, or whether you used it for self-diagnosis or medical treatment, whether in relation to each other in person or in relation to others.

I declare:

  1. that I have met the above instruction
  2. I'm an expert within the meaning of the Act n.40/1995 Coll. the regulation of advertising, as amended, and I am aware of the risks that would be a person other than the expert input to these sites exhibited


No

Yes

If your statement is not true, please be aware
that brings the risk of danger to their health or the health of others.